Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma

被引：0
|
作者：
Huang, Beihui
Li, Juan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4532
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma
    Gupta, Ritu
    Kumar, Lalit
    Dahiya, Meetu
    Mathur, Nitin
    Harish, P.
    Sharma, Atul
    Sharma, Om Dutt
    Shekhar, Varun
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1234 - 1237
  • [12] Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas
    J Gauthier
    L Holmberg
    D Wu
    W Bensinger
    A K Gopal
    O Press
    D Maloney
    D J Green
    B G Till
    D Byelykh
    A Shustov
    Bone Marrow Transplantation, 2016, 51 : 1617 - 1619
  • [13] Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas
    Gauthier, J.
    Holmberg, L.
    Wu, D.
    Bensinger, W.
    Gopal, A. K.
    Press, O.
    Maloney, D.
    Green, D. J.
    Till, B. G.
    Byelykh, D.
    Shustov, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (12) : 1617 - 1619
  • [14] Minimal residual disease testing after stem cell transplantation for multiple myeloma
    A M Sherrod
    P Hari
    C A Mosse
    R C Walker
    R F Cornell
    Bone Marrow Transplantation, 2016, 51 : 2 - 12
  • [15] Minimal residual disease testing after stem cell transplantation for multiple myeloma
    Sherrod, A. M.
    Hari, P.
    Mosse, C. A.
    Walker, R. C.
    Cornell, R. F.
    BONE MARROW TRANSPLANTATION, 2016, 51 (01) : 2 - 12
  • [16] Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Boncompagni, Riccardo
    Staderini, Michela
    Nozzoli, Chiara
    Antonioli, Elisabetta
    Caporale, Roberto
    Peruzzi, Benedetta
    Cutini, Ilaria
    Gozzini, Antonella
    Serena, Mariotti
    Guidi, Stefano
    Jance, Blerina
    Accogli, Barbara
    Francesco, Annunziato
    Bosi, Alberto
    Saccardi, Riccardo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E172 - E172
  • [17] Outcome of Autologous Stem Cell Transplantation in High-Risk Multiple Myeloma: A Single-Center Experience
    Pincha, Rajat
    Ghosh, Shouriyo
    Podder, Dibakar
    Kumar, Jeevan
    Nag, Arijit
    Javed, Rizwan
    Chattopadhyay, Debranjani
    Mishra, Deepak
    Parihar, Mayur
    Nair, Reena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S565 - S565
  • [18] Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
    Rajkumar, SV
    Fonseca, R
    Lacy, MQ
    Witzig, TE
    Lust, JA
    Greipp, PR
    Therneau, TM
    Kyle, RA
    Litzow, MR
    Gertz, MA
    BONE MARROW TRANSPLANTATION, 1999, 24 (05) : 497 - 503
  • [19] Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
    SV Rajkumar
    R Fonseca
    MQ Lacy
    TE Witzig
    JA Lust
    PR Greipp
    TM Therneau
    RA Kyle
    MR Litzow
    MA Gertz
    Bone Marrow Transplantation, 1999, 24 : 497 - 503
  • [20] Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
    Rawstron, Andy C.
    Child, J. Anthony
    de Tute, Ruth M.
    Davies, Faith E.
    Gregory, Walter M.
    Bell, Sue E.
    Szubert, Alexander J.
    Navarro-Coy, Nuria
    Drayson, Mark T.
    Feyler, Sylvia
    Ross, Fiona M.
    Cook, Gordon
    Jackson, Graham H.
    Morgan, Gareth J.
    Owen, Roger G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2540 - +
12345